Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

~26 mi. (Lublin, Poland, +199 more cities)

Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie ( Site 0620)

Hepatocellular Carcinoma

pembrolizumab

immunotherapy

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

~26 mi. (Lublin, Poland, +202 more cities)

Site PL48004

CLDN18 Expression, +1 more biomarker

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

modified FOLFOX6 regimen, +1 more drug

chemotherapy, +1 more type

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

~26 mi. (Lublin, Poland, +201 more cities)

Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie /ID# 221667

Myelodysplastic Syndromes

azacitidine, +1 more drug

chemotherapy

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

~26 mi. (Lublin, Poland, +189 more cities)

Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie /ID# 221124

del(11)(q10), +27 more biomarkers

Myelofibrosis Transformation in Essential Thrombocythemia, +2 more conditions

navitoclax, +1 more drug

targeted therapy

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

~26 mi. (Lublin, Poland, +108 more cities)

Samodzielny Publiczny Szpital Kliniczny Number 1 w Lublinie

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

cytarabine, +5 more drugs

chemotherapy, +2 more types

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

~61 mi. (Radom, Poland, +144 more cities)

Radomskie Centrum Onkologii ( Site 2418)

Clear Cell Renal Cell Carcinoma

belzutifan, +3 more drugs

immunotherapy, +1 more type

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

~88 mi. (Warszówka, Poland, +36 more cities)

Research Site

Prostate Adenocarcinoma

abiraterone, +1 more drug

hormone therapy

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

~92 mi. (Kielce, Poland, +176 more cities)

Swietokrzyskie Centrum Onkologii SPZOZ ( Site 2485)

Endometrial Carcinoma, +1 more condition

chemotherapy, +2 more drugs

chemotherapy, +2 more types

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~92 mi. (Siedlce, Poland, +130 more cities)

Urologica Praktyka Lekarska Adam Marcheluk ( Site 0654)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

~99 mi. (Otwock, Poland, +159 more cities)

Europejskie Centrum Zdrowia Otwock ( Site 1057)

Superficial Bladder Urothelial Carcinoma

cisplatin, +2 more drugs

chemotherapy, +1 more type